References
- 1..Suzuki M, Takahashi T. Aberrant DNA replication in cancer. Mutat Res. 2013;743–744:111–7.
- 2..Hu T, Chitnis N, Monos D, Dinh A. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82(11):801–11.
- 3..Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018;109(3):513–22.
- 4..Roy S, Juste SS, Sneider M, Auradkar A, Klanseck C, Li Z, et al. Cas9/nickase-induced allelic conversion by homologous chromosome-templated repair in Drosophila somatic cells. Sci Adv. 2022;8(26):eabo0721.
- 5..Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 2016;353(6305): aaf8729.
- 6..Wang Q, Liu J, Janssen JM, Gonçalves MAFV. Precise homology-directed installation of large genomic edits in human cells with cleaving and nicking high-specificity Cas9 variants. Nucleic Acids Res. 2023;51(7):3465–84.

